The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options-Reference-Cited by-同舟云学术

The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options

Published:2015-12 Issue: Volume:46 Page:S47-S50
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Postma Nynke,Kiers Dorien,Pickkers Peter

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference50 articles.

1. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia;Bartlett;N Engl J Med,1978

2. Clostridium difficile-associated disease in US hospitals, 1993–2005: statistical brief #50. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs;Elixhauser,2006

3. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001–2010;Reveles;Am J Infect Control,2014

4. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027;Pépin;Am J Gastroenterol,2007

5. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals;Johnson;N Engl J Med,1999

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database;Expert Opinion on Drug Safety;2024-04-11

2. Survivability of Clostridioides difficile spores in fermented pork summer sausage during refrigerated storage;Veterinary World;2022-01-27

3. Reducing the Healthcare-Associated Infections in a Rehabilitation Hospital under the Guidance of Lean Six Sigma and DMAIC;Healthcare;2021-12-01

4. A model screening pipeline for bile acid converting anti-Clostridioides difficile bacteria reveals unique biotherapeutic potential of Peptacetobacter hiranonis;2021-09-30

5. Analysis of Routine and Integrative Data from Clostridioides difficile Infection Diagnosis and the Consequent Observations;The Open Microbiology Journal;2019-12-31